The investment by Continuity Biosciences LLC into PinPrint Inc. will expand the company’s footprint from therapeutic to ...

--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today ...

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its ...

“2025 is shaping up to be a milestone year for Pulse Biosciences. Our early clinical ... In addition to its booth and technology suite, Nanosecond PFA Technology will be featured at several ...

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, ...

Cytek Biosciences, Inc. is highlighting its Full Spectrum Profiling™ (FSP®) technology at the upcoming CYTO 2025 and IMMUNOLOGY2025 conferences to promote advancements in cell analysis.

University of Hyderabad and Krismo Biosciences collaborate to develop antibody-based therapies for infectious diseases and toxins.

April 25, 2025--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that its Nanosecond PFA ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that its ...